Media coverage
13
Media coverage
Title New asundexian Phase III study to include patients with atrial fibrillation ineligible for oral anticoagulant treatment Media name/outlet Business Wire Country/Territory United States Date 10/11/23 URL ct.moreover.com/?a=52299123729&p=1gw&v=1&x=UzMOgISygJHfDnrtIvc6LQ Persons Roxana Mehran, Title New asundexian Phase III study to include patients with atrial fibrillation ineligible for oral anticoagulant treatment Media name/outlet Morningstar.com Country/Territory United States Date 10/11/23 URL ct.moreover.com/?a=52299200207&p=1gw&v=1&x=6YgutZIxt54FS9KKcOyzuA Persons Roxana Mehran, Title New asundexian Phase III study to include patients with atrial fibrillation ineligible for oral anticoagulant treatment Media name/outlet Street Insider Country/Territory United States Date 10/11/23 URL ct.moreover.com/?a=52299115995&p=1gw&v=1&x=BuPofMIsI41zPCLF6cSllQ Persons Roxana Mehran, Title New asundexian Phase III study to include patients with atrial fibrillation ineligible for oral anticoagulant treatment Media name/outlet PharmiWeb Country/Territory United Kingdom Date 10/11/23 URL ct.moreover.com/?a=52300201909&p=1gw&v=1&x=tHOSqg2Z69veVbiAIEcQSQ Persons Roxana Mehran, Title New asundexian Phase III study to include patients with atrial fibrillation ineligible for oral anticoagulant treatment Media name/outlet BioSpace Country/Territory United States Date 10/11/23 URL ct.moreover.com/?a=52299789677&p=1gw&v=1&x=qzVD0Fk-JUQJq31HTwszTg Persons Roxana Mehran, Title New asundexian Phase III study to include patients with atrial fibrillation ineligible for oral anticoagulant treatment Media name/outlet Yahoo! Finance Country/Territory United States Date 10/11/23 URL ct.moreover.com/?a=52299249485&p=1gw&v=1&x=GHvTgtSGjpi5FMOYS8GOGg Persons Roxana Mehran, Title New asundexian Phase III study to include patients Media name/outlet Sogotrade - Barchart.com Country/Territory United States Date 10/11/23 URL ct.moreover.com/?a=52299115459&p=1gw&v=1&x=aRARccGCi5SNaT0zRBHTVQ Persons Roxana Mehran, Title New asundexian Phase III study to include patients with atrial fibrillation ineligible for oral anticoagulant treatment Media name/outlet Le Lezard.com Country/Territory Canada Date 10/11/23 URL ct.moreover.com/?a=52299142485&p=1gw&v=1&x=7VVA4E4sQcnzXwoFDP6igg Persons Roxana Mehran, Title New asundexian Phase III study to include patients with atrial fibrillation ineligible for oral anticoagulant treatment Media name/outlet ADVFN US Country/Territory United States Date 10/11/23 URL ct.moreover.com/?a=52299139286&p=1gw&v=1&x=-Mg8pEHvb59j3kyod3rarg Persons Roxana Mehran, Title New asundexian Phase III study to include patients with atrial fibrillation ineligible for oral anticoagulant treatment Media name/outlet Pharmaceutical Daily Country/Territory Bosnia and Herzegovina Date 10/11/23 URL ct.moreover.com/?a=52300296623&p=1gw&v=1&x=79G1ZIifqFRx279CrBghjA Persons Roxana Mehran, Title New asundexian Phase III study to include patients with atrial fibrillation ineligible for oral anticoagulant treatment Media name/outlet Acrofan Date 10/11/23 URL ct.moreover.com/?a=52299144150&p=1gw&v=1&x=CLNevZKCFM_E-WmPTN0RKA Persons Roxana Mehran, Title New asundexian Phase III study to include patients with atrial fibrillation ineligible for oral anticoagulant treatment Media name/outlet EIN Presswire Country/Territory United States Date 10/11/23 URL ct.moreover.com/?a=52299324986&p=1gw&v=1&x=hbOxNo71MPeKtis7TxueFg Persons Roxana Mehran, Title New asundexian Phase III study to include patients with atrial fibrillation ineligible for oral anticoagulant treatment Media name/outlet Valdosta Daily Times Country/Territory Georgia Date 10/11/23 URL ct.moreover.com/?a=52299255536&p=1gw&v=1&x=UxJxuEoqwmZWAr12p_Uz6Q Persons Roxana Mehran,